ClinicalTrials.Veeva

Menu

Safety and Efficacy Study of Gamaline+Hipericin in PMS (GH)

P

Phytopharm Consulting Brazil

Status

Unknown

Conditions

Edema
Irritability
Hot Flashes
Depression
Anxiety

Study type

Observational

Funder types

Other
NETWORK
Industry

Identifiers

NCT01283568
GAMALINEHIPERICIN

Details and patient eligibility

About

GAMALINE is already register for PMS and HIPERICIN as antidepressive drug. Both plant extracts. The investigators will try the mixture and see if the vasomotor symptoms will disappear. The investigators expect that together all symptoms will be covered better than Gamaline alone. The investigators will run for 180 days measuring at T0, T1 and T6 (starting point, 30 days and 180 days).

Full description

This protocol wants to show the advantages for the mixture GAMALINE 900mg+HIPERICIN 300mg - 2 herbal extracts for PMS treatment against the individual use of GAMALINE

Enrollment

240 estimated patients

Sex

Female

Ages

25 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • climacteric pre-menopausal women between 45 e 55 anos
  • women between 25 e 44 anos

Exclusion criteria

  • Age inferior 25 anos or superior 55 anos and/or decline invitation.
  • Patients pos-menopause
  • Under hormone therapy
  • Thyroid disease
  • Under psychiatric therapy or medication
  • History for allergies and hypersensitivity to one or both extracts
  • Breast feeding or pregnancy
  • No knowledge for writing and/or reading

Trial design

240 participants in 4 patient groups

1 - Gamaline+Hipericin - fertile women
2- Gamaline+Hipericin - climateric women
3- Gamaline- control - fertile women
4 - Gamaline control - climateric women

Trial contacts and locations

1

Loading...

Central trial contact

Carla Vanin, MD MSc PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems